INTRODUCTION
LPS plays an important role in the recognition of Gramnegative bacteria by cells of the innate immune system. The cellular recognition of LPS proceeds via the LPS receptor complex. [1] [2] [3] [4] LPS signal transduction leading to cell activation is mediated by TLR4, the protagonist molecule of the LPS receptor complex. 1, 2 In LPS-resistant mice carrying defects in tlr4, LPS unresponsiveness is accompanied by an enhanced sensitivity to Gram-negative infections. 5 Similarly, the reduced LPS sensitivity of mice with disrupted lbp, the gene coding for the LPS binding protein in plasma, was found to be paralleled by an enhanced susceptibility to Salmonella typhimurium infection. 6 
Micro-organisms-induced hypersensitivity to LPS
In animal colonies kept under conventional conditions, occasionally an enhancement of LPS sensitivity can be observed. LPS hypersensitivity can also be induced experimentally by a variety of treatments. 7 Among others, pretreatment of mice with certain live (infection) or killed pathogens strongly increases the susceptibility to LPS leading to an enhancement of cytokine production and of incidence of endotoxin shock upon LPS treatment. 8 Importantly, LPS hypersensitive mice are concomitantly hypersensitive to other biologically active microbial components, 9 such as lipopeptides. 10 Furthermore, they are especially hypersensitive to the activity of the endogenous mediator TNF-a. 8 
IFN-g-and IFN-b-mediated sensitization to LPS
Investigations into the mechanisms of the LPS hypersensitivity induced by bacteria and other micro-organisms revealed an essential role for interferon-g (IFN-g) in its development. Thus, the development of LPS hypersensitivity induced by bacteria, such as Propionibacterium
The innate immune response to Gram-negative bacteria depends mainly on the ability of the host to respond to the LPS component. Consequently, the state of LPS sensitivity at the time of infection and the numbers of invading bacteria (i.e. the amounts of LPS) are primary factors determining the innate responses provoked by Gram-negative pathogens. LPS sensitivity increases following treatment of mice with live or killed micro-organisms. Two types of sensitization have been recognized, strong, IFN-g-dependent and moderate IFN-g-independent. IL-12 and IL-18 are intimately involved in the induction of IFN-g by bacteria. We showed that Gram-negative bacteria induce IFN-g in mice also by an IFN-b-dependent pathway that requires IL-18 and is independent of IL-12 signaling. This pathway is STAT4 dependent, the activation of which is directly linked to IFN-b. Further, IFN-b can be replaced by IFN-a. While different components of Gram-negative bacteria induce IL-12 and IL-18, LPS seems to be the only component in these bacteria capable of inducing IFN-b. Therefore, the IFN-b pathway of IFN-g induction, unlike the IL-12 pathway, proceeds only in LPS responder mice. The IFN-a/b-dependent pathway is expected to play a role whenever IFN-a or IFN-b, and IL-18 are produced concomitantly during infection.
acnes, S. typhimurium or Coxiella burneti could be inhibited by anti-IFN-g antibodies (unpublished data) 11 and was largely absent in mice with an impaired IFN-g production or function. 5, 8 The IFN-g-mediated sensitization is usually very strong. Mice thus sensitized may exhibit up to 1000-fold higher LPS susceptibility.
In lymphocytic choriomeningitis virus (LCMV) infected mice, an alternative mechanism of LPS sensitization has been described more recently. 12 This type of sensitization is mediated by IFN-a/b and is IFN-g-independent. The sensitivity of infected mice, determined by measuring TNF-a and lethal responses to LPS was found to increase by a factor of maximally 6. Possible changes in sensitivity to microbial constituents other than LPS, or to endogenous cytokines were not mentioned here nor have they been reported elsewhere.
Induction of IFN-g by Gram-negative bacteria
The induction of IFN-g by micro-organisms involves complex pathways. IL-12 and IL-18 are two cytokines intimately involved in the induction of IFN-g by bacteria and other microbial agents. Both cytokines were shown to possess IFN-g-inducing activity and/or to synergize with each other in its induction. 13, 14 In addition to the IL-12 (IL-18)-pathway, IL-12-independent pathway(s) of microbial induction exist. This became apparent when the IFN-g responses to Gram-negative bacteria of splenocytes of IL-12 -/and wild-type mice were compared. 15 Both types of cells exhibited IFN-g responses, whereby the responses of IL-12 -/splenocytes were 20-80% of those of wild-type cells. During the last years evidence has accumulated that IFN-a/b is an important molecule in the IL-12-independent pathway of microbial IFN-g induction. 16 
Induction of IFN-b by Gram-negative bacteria
IFN-a/b is strongly induced by viruses and dsRNA. In mice, IFN-b, but not IFN-a, is induced also by Gram-negative bacteria. In our studies, the induction of IFN-b by Gram-negative bacteria was found to be due to the LPS component and thus proceeded only in LPS-responder mice. 17 LPS non-responder mice produce no IFN-b when stimulated with Gram-negative bacteria in vivo or in vitro. Thus, macrophages of TLR4-deficient mice produce no detectable IFN-b mRNA ( Fig. 1 ) and IFN-b protein in response to different Gram-negative bacteria, while macrophages of the corresponding wild-type mice do. In contrast, the induction of IL-12 and IL-18 is not restricted to TLR4 signaling and proceeds in both LPS responder and in the non-responder C3H/HeJ, BALB/c/l and C57BL/10ScN mice (unpublished data). 17 Consequently, the IL-12 (IL-18)-pathway of IFN-g induction is present in LPS non-responder mice, while that involving IFN-b is absent. In LPS non-responder C57/BL10ScCr (Cr) mice, both pathways of IFN-g induction by Gram-negative bacteria are blocked. This is due to an additional defect of Cr mice, a point mutation of the Il12rb2 gene, leading to an IL-12 unresponsiveness. 18 Several Gram-positive bacteria (P. acnes, Staphylococcus aureus, Streptococcus thermophilus and Listeria monocytogenes) investigated so far induced no IFN-a/b in mice ( Fig. 1 ). 17 It seems, therefore, that IFN-a/b does not play a role in the induction of IFN-g by Gram-positive bacteria. Many cytokine-inducing constituents of Gram-positive bacteria, such as lipopeptides, lipoteichoic acids, peptidoglycan or lipoarabinomannan were shown to be TLR2 agonists. 19 It was reported recently that TLR2 agonists, in contrast to TLR4 ligands are, if at all, poor inducers of IFN-b. 20 LPS emerges as the only bacterial component endowing a large group of micro-organisms with IFN-b
Role of interferons in LPS hypersensitivity 309 Fig. 1 . Induction of IFN-b by LPS and bacteria in murine macrophages. Macrophages (10 6 /ml) were treated for 3 h with the agents indicated. IFN-b and TNF-a mRNA were detected by Northern blot analysis of total macrophage RNA. 17 inducing activity. It cannot be excluded that exceptions may be encountered in the future, and that the one or other Gram-positive micro-organism is found to express IFN-a/b inducing activity.
The role of IFN-b in the IFN-g response to Gram-negative bacteria
The role of IFN-b in the IFN-g induction became evident during our earlier study in which the impaired IFN-g production of Cr mice was investigated. 21 In that study, the supplementation of Cr splenocytes with IFN-b enabled IFN-g production in Gram-negative bacteria-stimulated cells. Later, Cr mice were identified as being unresponsive to IL-12 18, 22 and it was concluded retrospectively that the IFN-b-mediated induction of IFN-g was IL-12 independent. Furthermore, the IFN-g response to S. typhimurium of splenocytes from closely related LPS responder C57/BL10ScSn mice, with an intact TLR4 and an intact IL-12 receptor b2 chain could be partly inhibited by polyclonal or monoclonal anti-IFN-b. 21 Evidence for the involvement of IFN-b in the IL-12-independent production of IFN-g is shown also in Figure 2 . Addition of anti-IFN-b (but not anti-IFN-a) to the splenocyte cultures of IL-12 -/deficient mice reduced the IFN-g response to S. typhimurium. Furthermore, the addition of murine recombinant (mr) IFN-b enhanced the response of IL-12 -/splenocytes to bacteria. mrIFN-a could substitute for mrIFN-b in the enhancement of IFN-g response (not shown in Fig. 2 ). However, neither IFN-a nor IFN-b alone induced IFN-g responses in murine splenocytes.
Synergistic IFN-a/b/IL-18 pathway of IFN-g induction 15
The above results indicate that together with IFN-b, additional factors induced by bacteria participated in the induction of IFN-g. One obvious candidate is IL-18. The addition of IL-18 binding protein (IL-18BP), an inhibitor of IL-18 activity, reduced substantially the IFN-g response of wild-type (not shown) and IL-12 -/splenocytes (Fig. 2) to S. typhimurium. IL-18BP also showed strong inhibition (70 and 80%) in spleen cell cultures treated additionally with exogenous IFN-b.
In further experiments, we used mrIFN-a/b and mrIL-18 to investigate if these two cytokines suffice to induce IFN-g in the absence of bacteria. While neither of the two cytokines alone induced IFN-g, the combination of the two elicited formation of IFN-g in splenocytes of wild-type and IL-12 -/splenocytes (Fig. 3) . The combination of human IFN-a (Roferon A) with IL-18 failed to induce IFN-g in murine splenocytes showing that Roferon A cannot replace murine IFN-a/b in this pathway. From these results, we concluded that, in mice, bacteria-elicited IFN-b and IL-18 synergize in an IL-12-independent pathway of IFN-g induction. Fig. 2. IFN-b and IL-18 participate in the IL-12-independent induction of IFN-g by S. typhimurium. Splenocytes (2 x 10 6 /0.2 ml) of IL-12p35/p40 -/-(IL-12 -/-) mice were stimulated with heat-killed S. typhimurium alone or in combination with IFN-b (10 4 U) in the presence or absence of anti-IFN-b (5 mg), or IL-18BP (200 ng). IFN-g in culture supernatants was estimated by an ELISA. 15 One representative experiment of four is shown. Fig. 3 . IFN-a/b synergizes with IL-18 in the IL-12 independent induction of IFN-g that requires STAT4. Splenocytes (2 x 10 6 /0.2 ml) of the different mice strains were stimulated with combinations of IFN-b or IFN-a (10 4 U) and IL-18 (20 ng), or with each cytokine alone for 24 h. IFN-g in culture supernatants was estimated by an ELISA. 15 One representative experiment of three is shown.
STAT4, an essential factor of IL-12/IL-18-and IFNb/IL-18-dependent pathways of IFN-g induction by Gram-negative bacteria 15 The induction of IFN-g by the IL-12/IL-18-dependent pathway requires activation of transcription factor STAT4, which is a function of IL-12. Phosphorylated STAT4 binds directly to the IFN-g promoter and increases gene transcription. 23, 24 Furthermore, STAT4 participates in the induction of IL-18 receptor and adapter protein MyD88, which are involved in IL-18 signaling. These STAT4mediated effects are essential for the strong synergism of IL-12 with IL-18 in the induction of IFN-g. 25 IFN-a/b was shown to activate STAT4 in human cells, however failed to do so in mouse cells. 26 The inability of IFN-a/b to activate mouse STAT4 was explained by the identification of a minisatellite insertion into mouse Stat2 gene, which selectively disrupted the capacity of murine STAT2 to activate STAT4, but not other STATs. 27 The results led to the consensus that IFN-a/b cannot activate murine STAT4. 16 It was concluded that the mechanisms linking innate and adaptive immunity differ between mice and humans. Further, the validity of using mice for the study of human infection disease was questioned. It was therefore surprising that the IFN-g responses to bacteria, which according to our data are composed of at least of two pathways (IL-12/IL-18-and IFN-b/IL-18-dependent), were completely absent in splenocytes of STAT4 -/mice. Furthermore, mrIFN-a/b and IL-18, alone or in combination, were unable to induce IFN-g in STAT4 -/cells (Fig. 3) . These results indicated that the induction of IFN-g by IFN-a/b and IL-18 requires STAT4.
Induction of STAT4 phosphorylation by IFN-a/b 15
We next determined which of the two cytokines, IFNa/b or IL-18, was responsible for STAT4 phosphorylation. Splenocytes of wild-type and IL-12 -/mice were activated with Con A and re-stimulated for 15 min with murine IFN-b (Fig. 4) , IL-18, IL-12 or human IFN-a. The results revealed that murine IFN-b, as IL-12 induces STAT4 tyrosine phosphorylation, while murine IL-18 or human IFN-a are inactive. For the induction of tyrosinephosphorylated STAT4, IFN-b could be replaced by murine IFN-a. Thus murine IFN-a/b can induce recruitment of STAT4 to the IFN-a/b receptor and its subsequent phosphorylation. In this respect, the murine and human pathways obviously do not differ.
As mentioned above, IFN-a/b mediates a moderate sensitization to LPS by an IFN-g-independent pathway. 12 This study indicates that IFN a/b, when produced concomitantly with IL-18 during infection, can contribute to IFN-g production and thereby to the IFN-g-mediated sensitization to LPS, bacterial lipopeptides and TNF-a.
Interestingly, however, it was reported that IFN-a/b can also inhibit IFN-g production in virus-infected mice. 28 This effect is mediated by STAT1, since it was completely abrogated in the absence of STAT1. It is therefore conceivable to assume, that in the infected organism, under certain circumstances, IFN -a/b may inhibit the development of IFN-g-mediated sensitization to microbial constituents and to TNF-a. Obviously, infectioninduced IFN-a/b may exhibit both positive and negative effects on the recognition of pathogens and the subsequent inflammatory reaction. Fig. 4 . IFN-b-induced tyrosine phosphorylation of STAT4 in wild-type and IL-12 -/splenocytes. Con A-activated splenocytes (5 x 10 7 ) were stimulated at 37°C with IFN-b for 15 min. Cell lysates were immunoprecipitated with anti-STAT4 and immunobloted with anti-phosphotyrosine. Thereafter, the blots were stripped and re-probed with anti-STAT4. 15 One representative experiment of two is shown.
